MAURI, GIANLUCA
 Distribuzione geografica
Continente #
EU - Europa 1.148
NA - Nord America 1.034
AS - Asia 805
OC - Oceania 35
AF - Africa 34
SA - Sud America 14
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.071
Nazione #
US - Stati Uniti d'America 1.001
IT - Italia 534
CN - Cina 481
GB - Regno Unito 131
FR - Francia 110
DE - Germania 101
JP - Giappone 81
NL - Olanda 40
KR - Corea 37
HK - Hong Kong 33
ES - Italia 32
IN - India 31
AU - Australia 28
CA - Canada 28
UA - Ucraina 22
TW - Taiwan 21
CZ - Repubblica Ceca 19
SG - Singapore 17
IE - Irlanda 15
MK - Macedonia 15
AE - Emirati Arabi Uniti 14
CH - Svizzera 13
NO - Norvegia 13
RU - Federazione Russa 13
SE - Svezia 13
IR - Iran 12
PH - Filippine 12
TR - Turchia 12
BE - Belgio 11
DK - Danimarca 11
EG - Egitto 11
MY - Malesia 9
PT - Portogallo 9
FI - Finlandia 8
NZ - Nuova Zelanda 7
ZA - Sudafrica 7
BR - Brasile 6
GR - Grecia 6
IL - Israele 6
SA - Arabia Saudita 6
VN - Vietnam 6
AT - Austria 5
BD - Bangladesh 4
HR - Croazia 4
ID - Indonesia 4
MA - Marocco 4
MX - Messico 4
PK - Pakistan 4
PL - Polonia 4
RO - Romania 4
SK - Slovacchia (Repubblica Slovacca) 4
TH - Thailandia 4
CO - Colombia 3
ET - Etiopia 3
LU - Lussemburgo 3
TN - Tunisia 3
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
CL - Cile 2
CM - Camerun 2
IQ - Iraq 2
IS - Islanda 2
JO - Giordania 2
LB - Libano 2
LY - Libia 2
QA - Qatar 2
UY - Uruguay 2
AL - Albania 1
AP - ???statistics.table.value.countryCode.AP??? 1
CU - Cuba 1
DZ - Algeria 1
EC - Ecuador 1
KE - Kenya 1
KZ - Kazakistan 1
MO - Macao, regione amministrativa speciale della Cina 1
PS - Palestinian Territory 1
RS - Serbia 1
Totale 3.071
Città #
Milan 142
Beijing 111
Shanghai 63
Ashburn 61
Fairfield 50
Santa Cruz 50
Houston 49
Turin 42
Rome 36
Woodbridge 29
Hangzhou 28
Los Angeles 28
Cambridge 26
Guangzhou 26
Tokyo 23
Buffalo 22
Seattle 22
Council Bluffs 21
London 21
Ann Arbor 20
Munich 20
Boardman 18
Nanjing 18
New York 18
Chicago 17
Genoa 16
Paris 15
Taipei 14
Barcelona 12
Bari 12
Carrara 12
Dublin 12
Legnano 12
Redmond 12
Wilmington 12
Atlanta 11
Bologna 11
Mumbai 11
San Diego 11
Florence 10
Southend 10
Amsterdam 9
Central 9
Changsha 9
Oslo 9
Birmingham 8
Frankfurt am Main 8
Fuzhou 8
Skopje 8
Sydney 8
Wuhan 8
Chengdu 7
Des Moines 7
Manchester 7
Seoul 7
St Louis 7
Acqui Terme 6
Almere Stad 6
Incheon 6
Jinan 6
Melbourne 6
Milwaukee 6
Naples 6
Piscataway 6
Toronto 6
Washington 6
Zhengzhou 6
Basel 5
Berlin 5
Bethesda 5
Boston 5
Brooklyn 5
Cedar Knolls 5
Columbus 5
Fremont 5
Kuala Lumpur 5
Modesto 5
Newmarket 5
Nijmegen 5
Osaka 5
Ottawa 5
Philadelphia 5
Porto 5
Stockholm 5
Tübingen 5
Adelaide 4
Bratislava 4
Cairo 4
Cebu City 4
Dearborn 4
Denver 4
Heidelberg 4
Helsinki 4
Istanbul 4
Karachi 4
Kicevo 4
Lahug 4
Las Vegas 4
Leuven 4
Monza 4
Totale 1.489
Nome #
Strategies to tackle RAS-mutated metastatic colorectal cancer, file dfa8b9a7-c92c-748b-e053-3a05fe0a3a96 427
A subset of colorectal cancers with cross-sensitivity to olaparib and oxaliplatin, file dfa8b9a6-e2ef-748b-e053-3a05fe0a3a96 397
Early-onset colorectal cancer in young individuals, file dfa8b99d-fbfc-748b-e053-3a05fe0a3a96 298
A subset of colorectal cancers with cross-sensitivity to olaparib and oxaliplatin, file dfa8b9a0-6b21-748b-e053-3a05fe0a3a96 270
The DNA Damage Response pathway as a land of therapeutic opportunities for colorectal cancer, file dfa8b9a2-1d1f-748b-e053-3a05fe0a3a96 264
The evolutionary landscape of treatment for BRAFv600e mutant metastatic colorectal cancer, file dfa8b9a7-db17-748b-e053-3a05fe0a3a96 205
Increased incidence of colon cancer among individuals younger than 50 years : a 17 years analysis from the cancer registry of the municipality of Milan, Italy, file dfa8b99e-7431-748b-e053-3a05fe0a3a96 177
Genetic and pharmacological modulation of DNA mismatch repair heterogeneous tumors promotes immune surveillance, file a092074d-fe6b-433d-a2a5-2051892b9cc2 139
Mechanisms of immune escape and resistance to checkpoint inhibitor therapies in mismatch repair deficient metastatic colorectal cancers, file dfa8b9a7-ef89-748b-e053-3a05fe0a3a96 105
Temozolomide treatment alters mismatch repair and boosts mutational burden in tumor and blood of colorectal cancer patients, file 270635eb-59ad-428d-8d02-675025cf4486 101
Liquid Biopsy for Prognosis and Treatment in Metastatic Colorectal Cancer: Circulating Tumor Cells vs Circulating Tumor DNA, file dfa8b9a7-bc63-748b-e053-3a05fe0a3a96 98
Targeting the DNA Damage Response Pathways and Replication Stress in Colorectal Cancer, file b23c7eda-6ec5-4d3b-87a9-deecf8e58c98 83
Combined low densities of FoxP3+ and CD3+ tumor-infiltrating lymphocytes identify stage II colorectal cancer at high risk of progression, file dfa8b99d-eee6-748b-e053-3a05fe0a3a96 79
Long-term Clinical Outcome of Trastuzumab and Lapatinib for HER2-positive Metastatic Colorectal Cancer, file dfa8b9a7-f7e5-748b-e053-3a05fe0a3a96 72
Chemotherapy-induced myasthenic crisis in thymoma treated with primary chemotherapy with curative intent on mechanical ventilation: a case report and review of the literature, file dfa8b9a5-3e5c-748b-e053-3a05fe0a3a96 58
Empowering clinical decision making in oligometastatic colorectal cancer: The potential role of drug screening of patient-derived organoids, file dfa8b9a8-2429-748b-e053-3a05fe0a3a96 54
Delphi Initiative for Early-Onset Colorectal Cancer (DIRECt) International Management Guidelines, file 61e6d250-cdb9-4283-aaeb-e00ba4edd098 49
Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trial, file 52c6af08-a56d-4d21-a4db-cd075eaede5c 35
Circulating tumor DNA to drive treatment in metastatic colorectal cancer, file 6fc1269c-9760-4889-8031-9350f35d560f 33
Efficacy of Retreatment with Oxaliplatin-Based Regimens in Metastatic Colorectal Cancer Patients: The RETROX-CRC Retrospective Study, file c8ec4bad-23c9-49c6-8259-cbec5c98dd7c 32
Liquid biopsies to monitor and direct cancer treatment in colorectal cancer, file 37c52046-e7b6-4c04-a8eb-5a45391a7bdb 24
Temozolomide treatment alters mismatch repair and boosts mutational burden in tumor and blood of colorectal cancer patients, file dfa8b9aa-646b-748b-e053-3a05fe0a3a96 22
Case Report: MAP2K1 K57N mutation is associated with primary resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer, file 37efe537-8353-456f-bc77-c915a6f0739e 19
Clinicopathological characterisation of MTAP alterations in gastrointestinal cancers, file af6eb656-e08e-444f-9ad6-f41a9a163fec 14
Liquid Biopsy for Prognosis and Treatment in Metastatic Colorectal Cancer: Circulating Tumor Cells vs Circulating Tumor DNA, file 5eb3a027-5430-4a80-8af9-0f7e206a6983 13
Multimodal treatment with curative intent in a germline BRCA2 mutant metastatic ampullary adenocarcinoma: a case report, file b4d8959c-9ea3-4d0f-bc8a-daee9f2191fc 8
Oxaliplatin Immune-Induced Syndrome Occurs With Cumulative Administration and Rechallenge : Single Institution Series and Systematic Review Study, file dfa8b99a-e08f-748b-e053-3a05fe0a3a96 7
Oxaliplatin Immune-Induced Syndrome Occurs With Cumulative Administration and Rechallenge : Single Institution Series and Systematic Review Study, file dfa8b99a-afc7-748b-e053-3a05fe0a3a96 5
Parallel Evaluation of Circulating Tumor DNA and Circulating Tumor Cells in Metastatic Colorectal Cancer, file dfa8b99a-e72c-748b-e053-3a05fe0a3a96 4
Tolerance to colibactin correlates with homologous recombination proficiency and resistance to irinotecan in colorectal cancer cells, file f7848bc6-d7bc-476d-8071-6b04884919bb 4
Young-onset colorectal cancer: treatment-related nausea, vomiting and diarrhoea, file 174f0c27-5289-4007-84a8-9024bd796a2f 3
Parallel Evaluation of Circulating Tumor DNA and Circulating Tumor Cells in Metastatic Colorectal Cancer, file dfa8b99a-7a2f-748b-e053-3a05fe0a3a96 3
The predictive role of ERBB2 point mutations in metastatic colorectal cancer: A systematic review, file 9de16b7b-97c1-4ab3-b878-9755ea0c901e 2
Retreatment with anti-EGFR monoclonal antibodies in metastatic colorectal cancer: Systematic review of different strategies, file dfa8b99c-ed2c-748b-e053-3a05fe0a3a96 2
TRKA expression and NTRK1 gene copy number across solid tumours, file dfa8b99e-1869-748b-e053-3a05fe0a3a96 2
Benefit from upfront FOLFOXIRI and bevacizumab in BRAFV600E-mutated metastatic colorectal cancer patients: does primary tumour location matter?, file 0ba50c00-24d9-406e-ab4d-1bf6ae50cafe 1
The role of anti-EGFR rechallenge in metastatic colorectal cancer, from available data to future developments: A systematic review, file 332cab7f-088b-40d2-909e-a4b93dc525ac 1
Application of histology-agnostic treatments in metastatic colorectal cancer, file 5c68dc29-6812-4a25-85ec-4988bfdfb5f4 1
Combined low densities of FoxP3+ and CD3+ tumor-infiltrating lymphocytes identify stage II colorectal cancer at high risk of progression, file dfa8b99e-8aa4-748b-e053-3a05fe0a3a96 1
Oxaliplatin retreatment in metastatic colorectal cancer : systematic review and future research opportunities, file dfa8b9a3-9413-748b-e053-3a05fe0a3a96 1
Totale 3.113
Categoria #
all - tutte 7.170
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.170


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201931 0 0 0 0 0 0 0 0 0 0 17 14
2019/2020171 14 15 10 19 10 19 13 18 16 15 11 11
2020/2021157 8 7 6 11 12 9 12 12 11 19 12 38
2021/2022736 39 48 31 56 62 20 38 68 108 41 128 97
2022/2023977 63 57 132 82 88 109 67 56 56 78 89 100
2023/20241.018 84 72 98 127 161 90 138 96 71 71 10 0
Totale 3.113